DRUG (Bright Minds Biosciences) FCF Yield %: -2.26 (As of Jun. 27, 2026)


DRUG Bright Minds Biosciences Inc DRUG
34 GF Score
Price $65.79
! 2 Warning Signs
View Full Analysis

What is Bright Minds Biosciences FCF Yield %?

Bright Minds Biosciences DRUG +3.35% 34 FCF Yield % is -2.26 as of Jun. 27, 2026. GuruFocus rates DRUG with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 1,418 Biotechnology companies, Bright Minds Biosciences ranks better than 74.47% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Bright Minds Biosciences's Trailing 12-Month Free Cash Flow is $-14.44 Mil, and Market Cap is $617.47 Mil. Therefore, Bright Minds Biosciences's FCF Yield % for today is -2.26%.

The historical rank and industry rank for Bright Minds Biosciences's FCF Yield % or its related term are showing as below:

DRUG' s FCF Yield % Range Over the Past 10 Years
Min: -2.26   Med: 0   Max: 0
Current: -2.26

DRUG's FCF Yield % is ranked better than
74.47% of 1418 companies
in the Biotechnology industry
Industry Median: -9.715 vs DRUG: -2.26

Bright Minds Biosciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

Bright Minds Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Bright Minds Biosciences FCF Yield % Related Terms

Bright Minds Biosciences FCF Yield % Historical Data

* Premium members only.

The historical data trend for Bright Minds Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bright Minds Biosciences FCF Yield % Chart

Bright Minds Biosciences Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
FCF Yield %
Get a 7-Day Free Trial -6.83 -47.08 -86.01 -25.81 -1.36

Bright Minds Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.64 -5.54 -0.79 -2.78 -3.76

DRUG vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Bright Minds Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bright Minds Biosciences FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bright Minds Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Bright Minds Biosciences's FCF Yield % falls into.


DRUG
34GF Score
Bright Minds Biosciences Inc DRUG
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bright Minds Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Bright Minds Biosciences's FCF Yield % for the fiscal year that ended in Sep. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-6.283 / 463.19976
=-1.36%

Bright Minds Biosciences's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.739 * 4 / 715.98164
=-3.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -2.26 mean?
Bright Minds Biosciences (DRUG) has a FCF Yield % of -2.26 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Bright Minds Biosciences and its competitors. According to the industry distribution chart, Bright Minds Biosciences ranks #362 out of 1418 companies in the Biotechnology industry, placing it in the top 25.5%.
Is Bright Minds Biosciences' FCF Yield % too high?
Bright Minds Biosciences' current FCF Yield % is -2.26. Based on the distribution chart, Bright Minds Biosciences ranks #362 out of 1418 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bright Minds Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Bright Minds Biosciences' FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bright Minds Biosciences ranks #362 out of 1418 companies for FCF Yield %. This puts Bright Minds Biosciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Bright Minds Biosciences and its competitors. Bright Minds Biosciences's current FCF Yield % is -2.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bright Minds Biosciences stock overvalued right now?
Bright Minds Biosciences (DRUG) has a current FCF Yield % of -2.26. The current FCF Yield % is -2.26. Bright Minds Biosciences' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Bright Minds Biosciences (DRUG), the current FCF Yield % is -2.26 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bright Minds Biosciences Business Description

Other Exchanges DRUG:Canada
Address 19 Vestry Street, New York, NY, USA, 10013
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
34GF Score

Get the complete analysis for DRUG

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$65.79
Price